How do we make enough green hydrogen to fuel the world?
How can you prove 99.9% reliability? A challenge in automating and scaling cell therapies
Spatial biology: FISH and sequencing reveal gene expression patterns. Where is the industry now, and what will the future bring?
Translating spatial biology into tissue diagnostics with inventive technology
Diagnostic applications of spatial, multi-omic tissue analysis are emerging. Now we need new technologies to support the field of tissue pathology in making these insights available to clinicians caring for millions of patients.
Hydrogen: How do we keep track of the leakiest gas of all?
The need for hydrogen gas sensing is growing beyond its historic focus on leak detection to encompass a broader range of opportunities including blending, process control and metering. Is there one technology that can meet each of these very different opportunities?
Personalising neurostimulation in chronic pain management: tapping into the patient experience when we can’t measure pain
Nerve stimulation therapies for chronic pain can be very successful. But patients and clinicians face day-to-day challenges in the delivery of therapy that call for greater personalisation. Adaptive stimulation paradigms based on neural sensing data could help to achieve this – and give us additional insights.
Next-generation sample preparation: Will better nucleic acid extraction unleash biotechnology, life sciences and diagnostics?
Much is to be gained from developing next-generation sample preparation techniques to keep up with progress in DNA sequencing technology.
BVLOS for UAVs: How can we let smaller drones off the leash?
Beyond vision line of sight (BVLOS) or autonomous operation enabled by low SWaP-C Electronic Conspicuity and Detect and Avoid technology based on sensor fusion could unlock many business cases for lightweight UAVs.
Direct air capture: an industrial solution to the climate crisis?
Direct air capture is still too expensive for rollout at the scale required to meet net zero – but it need not be. Appetite for technology development is growing, safe in the knowledge that current demand for negative emissions technologies outstrips available capacity – and that future demand will be even greater.
Space safety: What can small satellites learn from drones?
The success of small satellite services will depend on safely scaling the operations of large satellite constellations in crowded orbits. Commercial drones face a similar challenge – and could have learnings and technology to offer.
Low-carbon hydrogen: the shift from centralised to distributed production and consumption is underway
The vision for how low-carbon hydrogen will be adopted is shifting. Could the revolution happen faster one vehicle or one boiler at a time? And if so, Who will pay for it?
Are uncrashable cars moving from an ambition to a necessity?
If the proposals of a UK legal review are implemented and copied internationally, operators of vehicles that are driving autonomously will become “users in charge”, manufacturers will become accountable as part of a very different regulatory system that assures safety, and autonomous vehicles (AVs) will need to become as good as uncrashable.
Will passive implantables be the next frontier in biosensing?
Technology developments have given us increasingly powerful and portable biosensors that can fit seamlessly into our lives – for example, glucose monitoring for diabetics. Consumer trends show there is further appetite for new technologies that provide accurate, reliable, affordable, discrete, and truly long-term biosensing.